Great update provided by MSB at the recent Nomura Asia forum and happy to hear many other trials (outside of Cardiovascular) are on track (Spinal Fusion; Knees ; long bones fractures ect.).
But I was most excited about Page 14 and the update on the MSB Intravenous franchise which includes the Big D !!
..." we are generating compelling pre-clinical data in each of these areas to support early commencement of Phase II trials ".
The possibility of starting Phase II trials in Humans with Diabetes is impelling and with 280 Million Diabetics worldwide ( 4% of the Global population and rising ) this will be 'world news' .
Just IMO. (always dyor).
MSB Price at posting:
$8.75 Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)